Tissue factor pathway inhibitor and the revised hypothesis of blood coagulation

Trends in Cardiovascular Medicine

Volumn 2, Issue 2, 1992, Pages 72-77

  Broze Jr , George J ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; THROMBOPLASTIN;

BLOOD CLOTTING; REVIEW;

EID: 0026575940     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/1050-1738(92)90008-G     Document Type: Short Survey

References (39)

1. Purification and characterization of bovine tissue factor
2. Purification and properties of human coagulation factor VII
3. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells
4. Characterization of the inhibition of tissue factor in serum
5. Purification of human brain tissue factor
6. a: insight into its possible mechanism of action
7. Regulation of coagulation by a multivalent Kunitz-type inhibitor
8. Identification of an endothelial cell product as an inhibitor of tissue factor activity
9. Waterfall sequence for intrinsic blood clotting
10. Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin induced intravascular coagulation in the rabbit
11. Factor XI activation in a revised model of blood coagulation
12. Functional significance of the Kunitz-type inhibitor domains of lipoprotein-associated coagulation inhibitor
13. Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2
14. Structure of the human lipoprotein-associated coagulation inhibitor gene: intron/exon gene organization and localization of the gene to chromosome 2
15. Characterization of a cDNA coding for human factor VII
16. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor
17. Intermediate reactions in the coagulation of blood with tissue thromboplastin
18. a and lipoproteins
19. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor
20. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier
21. An alternative extrinsic pathway of human blood coagulation
22. a in the presence of negatively charged surfaces
23. The reaction between bovine brain tissue factor and factors VII and X
24. Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation factor
25. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein-associated coagulation inhibitor
26. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma
27. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples
28. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation
29. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation
30. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.
31. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)
32. The active principle of placental toxin; thromboplastin; its inactivator in blood; antithromboplastin.
33. Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion
34. Studies on the intravascular thromboplastic effect of tissue suspensions in mice: a factor in normal rabbit serum which inhibits the thromboplastic effect of the sedimentable tissue component.
35. Intronexon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation
36. A sulfated rabbit endothelial cell glycoprotein that inhibits factor VIIa/tissue factor is functionally and immunologically identical to rabbit extrinsic pathway inhibitor
37. Evidence for the presence of tissue factor activity on subendothelium
38. Localization of tissue factor in the normal vessel wall and in atherosclerotic plaques
39. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains